Stephens Inc. AR Has $564,000 Stock Holdings in Agilent Technologies, Inc. $A

Stephens Inc. AR decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 76.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,780 shares of the medical research company’s stock after selling 15,242 shares during the period. Stephens Inc. AR’s holdings in Agilent Technologies were worth $564,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Generation Investment Management LLP raised its holdings in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after purchasing an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares during the last quarter. Mackenzie Financial Corp raised its holdings in shares of Agilent Technologies by 141.5% in the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock valued at $109,481,000 after purchasing an additional 548,344 shares during the last quarter. Woodline Partners LP raised its holdings in shares of Agilent Technologies by 681.6% in the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock valued at $61,072,000 after purchasing an additional 455,276 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of Agilent Technologies by 16.2% in the second quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock valued at $383,143,000 after purchasing an additional 447,207 shares during the last quarter.

Agilent Technologies Trading Up 0.4%

A stock opened at $148.03 on Friday. The company has a market capitalization of $41.97 billion, a PE ratio of 34.75, a price-to-earnings-growth ratio of 4.83 and a beta of 1.26. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company’s 50 day moving average price is $130.39 and its two-hundred day moving average price is $119.34. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business’s revenue was up 10.1% compared to the same quarter last year. During the same period last year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is presently 23.24%.

Analyst Ratings Changes

Several brokerages have recently commented on A. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Wells Fargo & Company increased their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Finally, Barclays increased their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.